Press release
Gouty Arthritis Market Research Reveals Path To $5.06 Billion By 2030
Gouty Arthritis Market
Gouty Arthritis Market Size Forecast and Growth Drivers
The gouty arthritis market is projected to reach a value of $5.06 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%. This upward trajectory is influenced by several important factors such as a rising elderly population, heightened awareness of chronic diseases, emphasis on preventive arthritis care, better adherence to treatment regimens, and the adoption of personalized treatment strategies tailored to individual patient needs. Additional market trends include a growing number of hyperuricemia cases, increased demand for sustained disease management programs, wider use of combination drug therapies, improved utilization of diagnostic imaging techniques, and expanded focus on lifestyle-based approaches to disease control.
The gouty arthritis market size has grown strongly in recent years. It will grow from $3.69 billion in 2025 to $3.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to dietary pattern changes, availability of NSAIDs, increased arthritis diagnosis, expansion of rheumatology clinics, pain management drug development.
Download a free sample of the gouty arthritis market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Leading Organizations Steering the Gouty Arthritis Market
Prominent companies active in the gouty arthritis market include Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, and Protalix BioTherapeutics Inc.
A notable development occurred in October 2023 when Amgen Inc., a US-based biotechnology firm, completed the acquisition of Horizon Therapeutics plc for $27.8 billion. This strategic move aims to enhance Amgen's portfolio in rare diseases and inflammatory conditions, broadening its therapeutic capabilities and accelerating revenue growth. Horizon Therapeutics, headquartered in Ireland, is known for its specialized gouty arthritis treatments.
View the full gouty arthritis market report:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Innovations and Advances in the Gouty Arthritis Industry
Companies in the gouty arthritis sector are intensifying their research efforts to bring innovative therapies to market, including products like cortrophin gel. Known medically as repository corticotropin injection, this purified form of adrenocorticotropic hormone (ACTH) is used to treat various inflammatory and autoimmune disorders, including gouty arthritis. An important milestone was reached in October 2023 when ANI Pharmaceuticals, a US-based company, obtained FDA approval for a new 1-mL vial size of Purified Cortrophin Gel. This therapy is designed as an adjunct treatment for certain patients experiencing acute gout flares. Cortrophin Gel remains the only FDA-approved ACTH therapy specifically indicated for managing acute gouty arthritis flare-ups.
Diverse Segments Defining the Gouty Arthritis Market
The gouty arthritis market is segmented across several key parameters:
1) By Type: Including Acute Gouty Arthritis and Chronic Gouty Arthritis
2) By Treatment Methods: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Relievers, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, and other therapies
3) By Diagnostic Tools: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, and additional methods
4) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, and other outlets
5) By End-Users: Hospitals, Specialty Clinics, and other healthcare providers
Subcategories within these segments offer further granularity. For Acute Gouty Arthritis, subtypes include Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack characterized by intermittent flares, and Severe Acute Gout involving joint deformities. Chronic Gouty Arthritis is further broken down into Tophaceous Gout (marked by uric acid deposits), Chronic Gout with joint damage, Chronic Gout with renal complications, and Chronic Gout accompanied by comorbid conditions such as hypertension or diabetes.
Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gouty Arthritis Market Research Reveals Path To $5.06 Billion By 2030 here
News-ID: 4607531 • Views: …
More Releases from The Business Research Company
Fluoxetine Market Report Examines Leading Companies And Growth Opportunities
Understanding the future outlook of the fluoxetine market reveals promising growth driven by advancements in mental health care and treatment accessibility. As awareness and demand for effective antidepressant therapies rise, this sector is poised for steady expansion through 2030. Let's delve into the market's size, key players, prevalent trends, and segmentation to gain a comprehensive picture of its trajectory.
Projected Size and Growth Rate of the Fluoxetine Market
The fluoxetine…
Flow Cytometry In Oncology And Immunology Market Outlook Highlights Strategic Op …
The flow cytometry market in oncology and immunology is poised for significant expansion as technological advancements and growing clinical needs drive its adoption. This sector is evolving rapidly, with increased integration of cutting-edge methods and broader applications in personalized medicine and research.
Projected Growth and Market Size of Flow Cytometry in Oncology and Immunology
The market for flow cytometry in oncology and immunology is anticipated to reach $3.82 billion by…
Flexible And Semi-Rigid Ureteroscopy Market Study Explores Industry Growth Towar …
The flexible and semi-rigid ureteroscopy market is set to experience notable expansion over the coming years, driven by technological advancements and evolving healthcare demands. This sector is responding to increased needs for minimally invasive procedures and improved diagnostic tools in urology, promising significant growth and innovation by 2030.
Projected Growth and Market Size of Flexible and Semi-Rigid Ureteroscopy
The market for flexible and semi-rigid ureteroscopy devices is anticipated to reach…
Guillain-Barre Syndrome Market Outlook Highlights Strategic Opportunities Across …
The Guillain-Barre Syndrome market is on the cusp of significant expansion as research advances and new treatments emerge. With growing attention on early diagnosis and innovative therapies, this sector is poised for notable growth in the coming years. Let's explore the market's projected size, leading players, emerging trends, and segmentation to better understand its trajectory.
Forecasted Growth and Market Size of the Guillain-Barre Syndrome Market
The market for Guillain-Barre Syndrome…
More Releases for Gout
Gout Disease Treatment Market Progress: Advancing Long-Term Care for Chronic Gou …
The global Gout Disease Treatment Market is witnessing sustained growth as healthcare systems place greater emphasis on the early diagnosis and long-term management of gout. As one of the most prevalent inflammatory arthritis conditions worldwide, gout requires continuous treatment to control uric acid levels, prevent recurrent flare-ups, and minimize long-term joint damage. Advances in treatment protocols, increasing patient awareness, and improved access to healthcare services are collectively driving the adoption…
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
